COMPASS Pathways: Funding, Investors & Team (Oct 2026)
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression. The company is involved in researching and developing psilocybin therapy, a psychedelic compound found in certain mushrooms, as a potential treatment for depression. Compass Pathways conducts clinical trials and research to assess the safety and efficacy of psilocybin-assisted therapy in patients who have not responded to conventional depression treatments. The company's goal is to bring evidence-based innovation to mental health care and address the significant unmet need for effective and accessible treatments for depression.
COMPASS Pathways has raised $460M across 4 funding rounds on record, the most recent an undisclosed round of $200M announced in Feb 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
COMPASS Pathways Company Profile and Key Stats
Latest funding round on record: Feb 2026.
COMPASS Pathways Funding Rounds
COMPASS Pathways raised $80.0M in an undisclosed round announced in Apr 2020.
3.3 years later, an undisclosed round of $30.0M was announced in Jul 2023.
1.5 years later, an undisclosed round of $150M was announced in Jan 2025.
1.1 years later, an undisclosed round of $200M was announced in Feb 2026.
COMPASS Pathways Founders and Leadership Team
Contact details for the COMPASS Pathways team: 1 of 3 have an email address on file.
Start 14-day free trial →COMPASS Pathways Funding Compared to Other Biotechnology Startups
COMPASS Pathways' latest round of $200M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like COMPASS Pathways in Biotechnology and Altrincham
Companies Similar to COMPASS Pathways
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
COMPASS Pathways Funding FAQs
What does COMPASS Pathways do?
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression. The company is involved in researching and developing psilocybin therapy, a psychedelic compound found in certain mushrooms, as a potential treatment for depression. Compass Pathways conducts clinical trials and research to assess the safety and efficacy of psilocybin-assisted therapy in patients who have not responded to conventional depression treatments. The company's goal is to bring evidence-based innovation to mental health care and address the significant unmet need for effective and accessible treatments for depression.
How much funding has COMPASS Pathways raised?
COMPASS Pathways has raised $460M across 4 rounds on record. The most recent is an undisclosed round of $200M announced in Feb 2026.
When did COMPASS Pathways last raise funding?
COMPASS Pathways' most recent funding round on record is an undisclosed round of $200M, announced in Feb 2026.
Who founded COMPASS Pathways?
FundedIQ lists Ekaterina Malievskaia (Founder), George Goldsmith (Founder) at COMPASS Pathways.
Who is the CEO of COMPASS Pathways?
Florian Brand is listed as CEO at COMPASS Pathways.
Where is COMPASS Pathways headquartered?
COMPASS Pathways is based in Altrincham, Cheshire, United Kingdom.
How many employees does COMPASS Pathways have?
COMPASS Pathways is in the 101-250 employee band.
How does COMPASS Pathways' funding compare to other Biotechnology startups?
COMPASS Pathways' latest round of $200M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's COMPASS Pathways Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for COMPASS Pathways is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.